Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Computational Drug Discovery Methods
TopicLeading institutions, researchers & key papers
This cluster of papers focuses on computational methods, virtual screening, and molecular docking techniques used in drug discovery. It covers topics such as drug target identification, pharmacokinetics, chemical properties, machine learning applications, polypharmacology, and network pharmacology.
201
Works
IDs:OpenAlex
How has Computational Drug Discovery Methods's publication output changed over time?
ScholarIQpublication output · 2007–2023
Output grew0% over the shown period — from 1 works in 2007 to 1 in 2023.
1
2
2
1
1
1
2
2
1
1
2007201020112012201620172019202020222023
What are the most-cited papers on Computational Drug Discovery Methods?
ScholarIQmost cited works
DrugBank 6.0: the DrugBank Knowledgebase for 2024
Craig Knox, Mike Wilson, Christen M. Klinger, Mark Franklin, Eponine Oler, Alexander E. Wilson, Allison Pon, Jordan J. Cox, Na Eun Chin, Seth A Strawbridge, Marysol García-Patiño, Ray Kruger, Aadhavya Sivakumaran, Selena Sanford, Rahil Doshi, Nitya Khetarpal, Omolola Fatokun, Daphnee Doucet, Ashley Zubkowski, Dorsa Yahya Rayat, Hayley Jackson, Karxena Harford, Afia Anjum, Mahi Zakir, Fei Wang, Siyang Tian, Brian Lee, Jaanus Liigand, Harrison Peters, Ruo Qi Wang, Tue Nguyen, Denise So, Matthew Sharp, Rodolfo da Silva, C. Gabriel, J.D. Scantlebury, Marissa Jasinski, David S. Ackerman, Timothy Jewison, Tanvir Sajed, Vasuk Gautam, David S. Wishart
S134668137. 20231,623 CitationsOPEN ACCESS
Alzheimer's disease: clinical trials and drug development
Francesca Mangialasche, Alina Solomon, Bengt Winblad, Patrizia Mecocci, Miia Kivipelto
S70053155. 20101,216 Citations
Seven Golden Rules for heuristic filtering of molecular formulas obtained by accurate mass spectrometry
Tobias Kind, Oliver Fiehn
S19032547. 20071,201 CitationsOPEN ACCESS
Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
Marina Sirota, Joel T. Dudley, Jeewon Kim, Annie Chiang, Alex A. Morgan, E. Alejandro Sweet‐Cordero, Julien Sage, Atul J. Butte
S24207032. 2011840 Citations
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Harald Hampel, Richard Frank, Karl Broich, Stefan Teipel, Russell Katz, John Hardy, Karl Herholz, Arun L.W. Bokde, Frank Jessen, Yvonne C. Hoessler, Wendy R. Sanhai, Henrik Zetterberg, Janet Woodcock, Kaj Blennow
S186543748. 2010633 Citations
Where is Computational Drug Discovery Methods research published, and who funds it?
ScholarIQvenues & funding sources
TOP JOURNALS
S190325471,729
S1346681371,623
S700531551,216
S186543748943
S24207032840
TOP FUNDERS
National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock
How much of the research on Computational Drug Discovery Methods is open access?
ScholarIQopen access share
60%OPEN ACCESS
Gold
33%
Green
7%
Hybrid
13%
Bronze
7%
Closed
40%
Related on ScholarIQ
Power failure: why small sample size undermines the reliability of neuroscience
Paper
Natural products in drug discovery: advances and opportunities
Paper
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
Paper
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Paper
Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective
Paper
Toxicity Testing in the 21st Century: A Vision and a Strategy
Paper